Search

Author/Creator Pirola, L.

1. AF.50 SAFETY AND CLINICAL EFFICACY OF THE DOUBLE SWITCH FROM ORIGINATOR INFLIXIMAB TO BIOSIMILARS CT-P13 AND SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (SCESICS): A MULTICENTER COHORT STUDY. (September 2021)

Authors:
Mazza, S.; Piazza O Sed, N.; Conforti, F.S.; Fascì, A.; Casini, V.; Ricci, C.; Munari, F.; Pirola, L.; Invernizzi, P.; Girelli, C.; Lupinacci, G.; Pastorelli, L.; Cavallaro, F.; Ferraris, L.; Colucci, A.; Amato, A.; Tontini, G.E.; Vecchi, M.; Fiorino, G.; Caprioli, F.
Journal:
Digestive and liver disease
Issue:
Volume 53(2021)Supplement 3
Page Start:
S159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗